HRB · H&R Block, Inc.

Current Thesis

H&R Block’s cash-return re-rating requires a recovery to its 2026-09-04 close of $49.06 with fiscal 2027 guidance intact; a weekly close below $44 invalidates that recovery thesis. The 2026-09-18 adjusted close was $44.25, leaving the market substantially weaker than at the September review despite the August earnings outlook.

The narrative is maturing — the 2026-08-11 results remain the operating anchor, while Argus lowered its target to $48 on 2026-09-09. That classification is an inference from the dated earnings, analyst revision and price deterioration; it is not evidence of measured investor outflows. The proximity of the September 18 close to the published invalidation condition supports low conviction in recovery occurring first. Argus report

Bullish and bearish views on H&R Block, Inc.

The model's bull view on H&R Block, Inc. (HRB), in brief: Operating growth supports the story. H&R Block reported fiscal 2026 revenue of $3.95 billion, up 4.9%, and operating cash flow of $838.7 million, up 23%, on 2026-08-11. These are measured operating results supporting the cash-return argument. Company results Repurchases improved… The bear view: Price confirmation has deteriorated. The adjusted market close fell from $49.06 on 2026-09-04 to $44.25 on 2026-09-18. The latest close remains above the published $44 weekly thesis-break condition, but these observations do not establish a defended support base. A recent target… Both cases follow in full.

Bull Case

• Operating growth supports the story. H&R Block reported fiscal 2026 revenue of $3.95 billion, up 4.9%, and operating cash flow of $838.7 million, up 23%, on 2026-08-11. These are measured operating results supporting the cash-return argument. Company results
• Repurchases improved per-share earnings. The 2026-08-11 release reported fiscal 2026 adjusted earnings per share (EPS) of $5.31, up 13.9%, and retirement of 7.9% of outstanding shares. The company spent $500.3 million on those repurchases. Company results
• Guidance supplies a measurable test. Management’s 2026-08-11 fiscal 2027 outlook specified revenue of $4.11–4.16 billion and adjusted diluted EPS of $6.04–6.24. A reduction in either range would undermine the operating premise behind recovery. Company outlook

Bear Case

• Price confirmation has deteriorated. The adjusted market close fell from $49.06 on 2026-09-04 to $44.25 on 2026-09-18. The latest close remains above the published $44 weekly thesis-break condition, but these observations do not establish a defended support base.
• A recent target moved lower. Argus’s 2026-09-09 quantitative report lowered its target to $48. This is a named analyst revision, not evidence that all analysts reduced their expectations. Argus report
• Tax assumptions constrain the outlook. The 2026-08-11 fiscal 2027 guidance assumes an effective tax rate of approximately 23%. A higher assumption accompanied by an EPS guidance reduction would weaken the earnings case. Company outlook

Setup & Price Structure

The 2026-09-18 adjusted price series records a $44.25 close, a three-month gain of 31.2%, and a price 17.6% below its $53.69 trailing-year high. Its 14-period relative strength index (RSI) reads 14.6. These measurements describe different horizons; the positive three-month change does not establish that the recent decline has ended.

The $44 weekly threshold is the research condition retained from the 2026-09-05 publication, rather than a newly verified chart shelf. Recovery would be observable through a weekly close at or above the September 4 reference close of $49.06 before the invalidation fires, with the operating outlook intact.

The supplied news record clusters earnings and market-mover coverage around 2026-08-11 and 2026-08-12. That sample is too small to establish retail crowding. No dated short-interest, fund-flow or moving-average measurements establish positioning in this review; RSI alone cannot identify who holds the shares.

Catalyst Calendar (next 30 days)

• 2026-10-06 — Quarterly dividend payment. The company’s dividend schedule confirms payment of $0.46 per share, declared on 2026-08-11 with a 2026-09-03 record date. This executes an announced distribution and does not resolve whether fiscal 2027 guidance is achievable. Company dividend schedule
• ~2026-11-05, estimated — Fiscal first-quarter results. This remains an unconfirmed estimate outside the next 30 days. As checked on 2026-09-19, the investor-relations page lists no upcoming earnings event; the report matters because it can reaffirm or reduce the August outlook. Company event listings

What Would Change Our Mind

Failure of the September recovery structure means a weekly close below $44. That condition ends the published price thesis even if the August guidance remains unchanged. A recovery to the September 4 reference close would not repair the fundamental argument if management had meanwhile reduced its fiscal 2027 outlook.

Conversely, a weekly close at or above $49.06 before that breach, with guidance intact, would satisfy the defined recovery case. The October 6 dividend payment alone cannot supply that confirmation.

Correlation Notes

This is a single-name tax-services and capital-return thesis, anchored in H&R Block’s 2026-08-11 results. The 31.2% three-month price gain measured on 2026-09-18 supplies no evidence of correlation with technology, healthcare or energy equities. Without paired return observations, a sector-correlation claim is unsupported.